NCT06747260View on ClinicalTrials.gov

Feasibility and Safety of Intranasally Administered Breast Milk in HIE

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 22, 2024

Primary Completion Date

September 22, 2025

Study Completion Date

January 1, 2030

Conditions
Hypoxic Ischaemic Encephalopathy (HIE)Hypoxic Ischemic Encephalopathy of NewbornNeonatal EncephalopathyNeonatal Hypoxic Ischemic EncephalopathyBrain InjuryPerinatal AsphyxiaPerinatal Asphyxia , Moderate to Severe HIE
Interventions
BIOLOGICAL

Intranasal breast milk

Neonates with hypoxic-ischemic encephalopathy receive their own-mother's fresh breast milk intranasally, starting from the first 48 hours of life and continuing for 28 days. Dose: 2 times daily, 0.4 ml in each nostril (15 minutes apart).

Trial Locations (1)

1083

RECRUITING

Division of Neonatology, Pediatric Center, Semmelweis University, Budapest, Hungary, Budapest

All Listed Sponsors
lead

Semmelweis University

OTHER